{"name": "Plexxikon",
 "permalink": "plexxikon",
 "crunchbase_url": "http://www.crunchbase.com/company/plexxikon",
 "homepage_url": "http://www.plexxikon.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2000,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@plexxikon.com",
 "phone_number": "510.647.4000",
 "description": "",
 "created_at": "Wed Mar 02 04:26:03 UTC 2011",
 "updated_at": "Wed Aug 03 03:29:51 UTC 2011",
 "overview": "\u003Cp\u003EPlexxikon, Inc. engages in the discovery and development of small molecule pharmaceuticals to treat human disease. \u003C/p\u003E\n\n\u003Cp\u003EThe company\u0026#8217;s products include PLX204 for the treatment of diabetes; PLX4032 for the treatment of melanoma and colorectal cancer; and PLX5568 kinase inhibitors for the treatment of pain, polycystic kidney disease, rheumatoid arthritis, metastatic breast cancer, and renal disease. \u003C/p\u003E\n\n\u003Cp\u003EIt develops a portfolio of clinical and preclinical stage programs in various therapeutic areas, including metabolic disease, such as obesity indications; oncology, such as osteolytic metastatic disease; and CNS, such as multiple sclerosis. The company\u00e2\u20ac\u2122s portfolio of clinical and preclinical stage programs for other therapeutic areas include inflammation, such as systemic lupus erythematosus, inflammatory bowel disease, and osteoporosis; and cardiovascular, including hypertension and atherosclerosis. \u003C/p\u003E\n\n\u003Cp\u003EPlexxikon, Inc. was founded in 2000 and is headquartered in Berkeley, California.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       32],
      "assets/images/resized/0012/4532/124532v1-max-150x150.png"],
     [[224,
       49],
      "assets/images/resized/0012/4532/124532v1-max-250x250.png"],
     [[224,
       49],
      "assets/images/resized/0012/4532/124532v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "K.",
      "last_name": "Peter Hirth",
      "permalink": "k-peter-hirth",
      "image": null}},
   {"is_past": false,
    "title": "President",
    "person":
     {"first_name": "Kathleen",
      "last_name": "Sereda Glaub",
      "permalink": "kathleen-sereda-glaub",
      "image": null}},
   {"is_past": true,
    "title": "Investor",
    "person":
     {"first_name": "Brian",
      "last_name": "K. Halak",
      "permalink": "brian-k-halak",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 935000000.0,
   "price_currency_code": "USD",
   "term_code": "cash_and_stock",
   "source_url": "http://www.daiichisankyo.com/news/20110301_289_E2.pdf",
   "source_description": "Plexxikon Inc. To Join Daiichi Sankyo Group",
   "acquired_year": 2011,
   "acquired_month": 2,
   "acquired_day": 28,
   "acquiring_company":
    {"name": "Daiichi Sankyo",
     "permalink": "daiichi-sankyo",
     "image":
      {"available_sizes":
        [[[150,
           23],
          "assets/images/resized/0012/4533/124533v1-max-150x150.png"],
         [[250,
           38],
          "assets/images/resized/0012/4533/124533v1-max-250x250.png"],
         [[324,
           50],
          "assets/images/resized/0012/4533/124533v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "91 Bolivar Drive",
    "address2": "",
    "zip_code": "94710",
    "city": "Berkeley",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}